Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
Options
BORIS DOI
Publisher DOI
Date of Publication
2009
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Language(s)
en
Contributor(s)
Viale, G. | |
Giobbie-Hurder, A. | |
Gusterson, B. A. | |
Maiorano, E. | |
Mastropasqua, M. G. | |
Sonzogni, A. | |
Mallon, E. | |
Colleoni, M. | |
Regan, M. M. | |
Price, K. N. | |
Brown, R. W. | |
Golouh, R. | |
Crivellari, D. | |
Karlsson, P. | |
Öhlschlegel, C. | |
Gelber, R. D. | |
Goldhirsch, A. | |
Coates, A. S. |
Additional Credits
Universitätsklinik für Medizinische Onkologie
Series
Annals of oncology
Publisher
Oxford University Press
ISSN
0923-7534
Access(Rights)
open.access